five

RNA-sequencing of PDAC cell lines exposed to MRTX1133 and/or MRTX1719

收藏
NIAID Data Ecosystem2026-05-02 收录
下载链接:
https://www.ncbi.nlm.nih.gov/sra/SRP539206
下载链接
链接失效反馈
官方服务:
资源简介:
To better understand the effects of a PRMT5 inhibitor (MRTX1719) alone or in combination with a KRAS inhibitor (MRTX1133), we treated PANC-1 pancreatic ductal adenocarcinoma cells (PDAC) with each of these inhibitors. We collected samples at 24, 72, and 144 hours post treatment and quantified gene expression changes using RNA-sequencing.
创建时间:
2025-06-26
二维码
社区交流群
二维码
科研交流群
商业服务